AI summary Trust: medium Third-party lab

LabG tested this Tirzepatide at 99.9% purity using HPLC and mass quantification. The tested quantity of 35.53mg significantly exceeded the 30mg label by 18.4%. Endotoxin status is not applicable. The test is older (6-12 months), and no batch ID was provided on the report. Customers can cross-check on the lab's public verification URL.

Watch out for
  • older (6-12 months)
  • no batch ID
  • quantity deviation (18.4%)
Test date
2025-11-05
Purity
99.90% 99.90%
Batch / lot
(no batch ID)
Lab
LabG
Quantity
label 30mg tested 35.53mg
Qty vs label
+18.4%
Endotoxins
n/a
Test score
5.2
Manufacturer
Shandong Aishi Biotechnology
View vendor dossier
Certificate

Test report image

Certificate scan
Certificate scan as published.
Source

Finnrick

✓ Artifact captured

We have the certificate image (SHA-256 hash captured) — you can verify it loads from the upstream lab and matches the artifact below.

Verify on upstream
Method
HPLC + mass quantification + endotoxins
Test type
finnrick_composite
Dose
30mg
Container
No Label / Copper Crimp / Clear Cap
Catalogued
2026-04-16
Artifact hash
83f5d9b4b2c50db0…
This COA is part of TitrateLab's community-trust corpus. See more from Shandong Aishi Biotechnology or learn how trust scores are computed on the methodology page.